See how company executives and directors have been buying or selling shares over the past 30 days. Insider trading activity can help investors better understand company leadership's actions.
Transactions0
Insider Involved0
Total Buys$0.00
Total Sells$0.00
Browse insider buying and selling activity reported to the SEC over the past year, including who traded, when they traded, and the value of each transaction.
No Insider Transactions found for Entasis Therapeutics Holdings Inc.
View older insider trading records reported to the SEC to research long-term buying and selling trends.
DATE INSIDER |
INSIDER | TYPE | SHARES | PRICE | SHARES PRICE VALUE |
|---|---|---|---|---|---|
Jul 11, 2022 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
7,598,814 | $2.20 | 7,598,814 $2.20 $16,717,391 |
Jul 08, 2022 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
11,671,662 | $2.20 | 11,671,662 $2.20 $25,677,656 |
Oct 19, 2021 Perros Manoussos |
Perros Manoussos
See Remarks
|
Sell |
11,974 | $3.19 | 11,974 $3.19 $38,197 |
Oct 19, 2021 Keiley Elizabeth M |
Keiley Elizabeth M
General Counsel
|
Sell |
3,759 | $3.19 | 3,759 $3.19 $11,991 |
Oct 19, 2021 Gutch Michael |
Gutch Michael
See Remarks
|
Sell |
3,759 | $3.19 | 3,759 $3.19 $11,991 |
Oct 19, 2021 Tommasi Ruben |
Tommasi Ruben
Chief Scientific Officer
|
Sell |
3,759 | $3.19 | 3,759 $3.19 $11,991 |
Oct 19, 2021 Altarac David |
Altarac David
CMO
|
Sell |
3,759 | $3.19 | 3,759 $3.19 $11,991 |
Oct 19, 2021 Mueller John Patrick |
Mueller John Patrick
Chief Development Officer
|
Sell |
4,001 | $3.19 | 4,001 $3.19 $12,763 |
Oct 19, 2021 Ronsheim Matthew |
Ronsheim Matthew
See Remarks
|
Sell |
3,759 | $3.19 | 3,759 $3.19 $11,991 |
Jun 11, 2021 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
6,268,975 | $2.00 | 6,268,975 $2.00 $12,537,950 |
Jun 11, 2021 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
6,268,975 | $2.00 | 6,268,975 $2.00 $5,544,281 |
May 03, 2021 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
3,731,025 | $2.00 | 3,731,025 $2.00 $2,597,913 |
May 03, 2021 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
3,731,025 | $2.00 | 3,731,025 $2.00 $7,462,050 |
Sep 01, 2020 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
4,672,897 | $2.68 | 4,672,897 $2.68 $3,885,981 |
Sep 01, 2020 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
4,672,897 | $2.68 | 4,672,897 $2.68 $12,499,999 |
Jun 11, 2020 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
12,677,490 | $2.50 | 12,677,490 $2.50 $11,337,479 |
Jun 11, 2020 Innoviva, Inc. |
Innoviva, Inc.
|
Buy |
12,677,490 | $2.50 | 12,677,490 $2.50 $31,693,725 |
Jan 09, 2020 Frazier Life Sciences VIII, L.P. |
Frazier Life Sciences VIII, L.P.
|
Sell |
50,000 | $5.00 | 50,000 $5.00 $250,010 |
Sep 28, 2018 Novo Holdings A/S |
Novo Holdings A/S
|
Buy |
1,089,835 | $15.00 | 1,089,835 $15.00 $16,347,525 |
Sep 28, 2018 Pivotal bioVenture Partners Fund I, L.P. |
Pivotal bioVenture Partners Fund I, L.P.
|
Buy |
337,724 | $15.00 | 337,724 $15.00 $5,065,860 |
TOP
